Now a Stand-alone Firm, AB Sciex to Invest Further into R&D, Explore Acquisition Opportunities

With its sale to Danaher closed, AB Sciex will invest further into development of its mass specs and explore acquiring new technologies to strengthen its technology portfolio, company officials said on Tuesday.

Thermo Fisher Increasing Mass Spec R&D Spend in 2010; Reports 7 Percent Spike in Q4 Revenues

CEO Marc Casper said the company is increasing R&D spending by $30 million for 2010, some of which will be directed at further building out its mass spec technology.

Children's Hospital Boston Researchers ID Protein That May Explain Paclitaxel Resistance

The researchers used a proteomics approach to discover that overexpression of prohibitin1 on the cell surface corresponded to resistance to the drug, one of the most successful cancer therapies in history.

NextGen Developing Biomarker Assays for Takeda

The assays will be used by the drug company for preclinical and clinical studies.

Oxford Nanopore Raises $28 Million to Start Protein Analysis Work, Continue DNA Sequencing Research

The UK firm's lead technology uses nanopores to measure electrical currents of molecules as they interact with the nanopores, and then identifies the molecules based on the current.

SAIC-Frederick Awards SDI Contract to Develop Antibodies for NCI's Proteomics Initiative

SDI will create antibodies for the NCI's CPTC initiative to improve the quality of antibodies for the proteomics community.

Recent Research Papers of Note

Included is a paper describing software to "establish an LC-MALDI-TOF/TOF-based targeted quantitative proteomics pipeline," and a platform with increased dynamic range for high-throughput proteomic studies.

New Products

NanoInk, Thermo Fisher Scientific

Movers & Shakers

Gail Page, Eric Fung, William Wallen, John Tran

Waters CEO Hints at New Platform, 'Exciting' Year for Mass Spec Business in 2010

In the midst of reporting a 3 percent revenue increase for Waters fourth quarter, CEO Douglas Berthiaume said a planned new quadrupole instrument launch, shipping of its Synapt G2 instrument, and mass spec-based stimulus grants could portend a strong year for the company's mass spec business.

Waters Begins Selling New Platform to Bridge HPLC to UPLC

The system is designed for researchers "who have been attracted by the promise of UPLC but remain reluctant to change largely because of their comfort levels with existing HPLC systems and techniques," a Waters official said.

Q&A: New Microarray Technology Combines Sensitivity of Western Blots, Scalability of RPAs

The technology, called microwestern arrays, "should allow advances in our understanding of cell context-specific networks underlying human disease when combined with appropriate computational modeling methods."

PerkinElmer Drops Legal Actions Against MDS, Life Tech; FTC Gives Nod to Analytical Technologies Sale

Following action by PerkinElmer that freed up the acquisition of the Life Technologies/MDS mass spec joint venture and MDS Analytical Technologies by Danaher, the FTC gave provisional approval of the Analytical Technologies sale.